Intervention

flaxseed

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6
Recruiting0
Common conditions9
Lead sponsors shown6
Advertisement

Clinical trials

6 shown
Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in MexicoNCT06683235 · 2024-11-01
ENROLLING_BY_INVITATION
The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese SubjectNCT02410668 · 2014-03-01
COMPLETED
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen TherapyNCT00956813 · 2009-10-01
COMPLETED
Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation TherapyNCT00955942 · 2007-12-01
TERMINATED
Flaxseed, Aromatase Inhibitors and Breast Tumor CharacteristicsNCT00612560 · 2007-11-01
COMPLETED
Low-Fat Diet and/or Flaxseed in Preventing Prostate CancerNCT00049309 · 2003-01-01
COMPLETED

Trial status mix

COMPLETED4
ENROLLING_BY_INVITATION1
TERMINATED1

Phase mix

NA2
PHASE22
PHASE32
PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.